BRIEF-Innocare Pharma Logs 9M Gross Margin 88.8%Nov 13 (Reuters) - InnoCare Pharma Ltd 688428.SS:
9M GROSS MARGIN 88.8%
JANUARY TO SEPTEMBER, TOTAL OPERATING REVENUE OF RMB1.12 BILLION
JANUARY TO SEPTEMBER, NET LOSS OF RMB72 MILLION
Further company coverage: 688428.SS
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments